Effect of Implementing Clinical Pathway among Pregnant Women with Pyelonephritis on Childbirth and Neonatal Outcome

Aida Abd El-Razek^1, , Gamila Gaber Ayoub¹ and Nawara Gaber AbdElmenem Elkholy¹

¹Maternal and Newborn Health Nursing, Faculty of Nursing, Menofia University, Egypt

Cite this paper:
Aida Abd El-Razek, Gamila Gaber Ayoub and Nawara Gaber AbdElmenem Elkholy. Effect of Implementing Clinical Pathway among Pregnant Women with Pyelonephritis on Childbirth and Neonatal Outcome. American Journal of Nursing Research. 2021; 9(5):156-163. doi: 10.12691/ajnr-9-5-1

Abstract

Aim of this study to determine the effect of implementing clinical pathway among pregnant Women with pyelonephritis on childbirth and neonatal outcomes. Design: A quasi –experimental design. Setting: The study was conducted at outpatient’s clinic of obstetric department at Shebin EL-Kom Teaching Hospital, Menoufia University hospital at Shebin EL-Kom. Subjects: Convenient sample was used all stuff nurses in the obstetric department (20 nurses) as well as 50 pregnant mothers will selected and divided into two equal groups; intervention group (25mothers who received clinical pathway during second trimester of pregnancy) and control group (25 mothers who not received clinical pathway). Instruments: interviewing questionnaire for pregnant mothers, & nurses and Observation checklist of neonatal outcomes. Results: The study revealed that there was highly significant improvement in women knowledge after implementing clinical pathway, there was significant improvement in nurse’s knowledge, childbirth, and neonatal outcomes. Conclusion: There was significant improvement was obvious among women relief of their reported symptoms and their knowledge about pyelonephritis and measures to relieve it. Recommendations: Improve the quality of health care provided through routine screening of pregnant women and applying workshops for nurses to improve their knowledge about pyelonephritis during pregnancy.

Keywords:
clinical pathway pyelonephritis childbirth neonate

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Wing, D. A., Fassett, M. J., & Getahun, D. (2014). Acute pyelonephritis in pregnancy: an 18-year retrospective analysis. American journal of obstetrics and gynecology, 210(3), 219-e1.
[2]	Jolley, J.A., & Wing, D.A. (2013). Pyelonephritis in pregnancy: an update on treatment options for optimal outcomes. Drugs 70(13): 1643-1655.
[3]	Cunningham, F.G., & Leveno, K.J. (2016). pyelonephritis in pregnancy, 24 a ed. Porto Alegre: AMGH.
[4]	Ovalle, A., & Levancini, M. (2012): Urinary tract infection in pregnancy. Curropinurol: 11(01): 55-59.
[5]	Artero, A., Alberola, J., Eiros, J. M., Nogueira, J. M & Cano, A. (2013): Pyelonephritis in pregnancy, How adequate is empirical treatment.Rev Esp 26(01): 30-33
[6]	Farkash, E., Weintraub, A.Y., Sergienko, R., Wiznitzer, A., Zlotnik, A., & Sheiner, E. (2012). Acute antepartum pyelonephritis in pregnancy: critical analysis of risk factors and outcomes .Eur J ObestetGynecol. RepordBiol: 162 (01): 24-27.
[7]	Snyder, C.C., Barton, J.R., Habli, M & Sibai, B.M. (2013). Sever sepsis and septic shock in pregnancy, Indication for delivery and maternal and perinatal outcomes. Med 26(05) 503-506.
[8]	Bryan, S., Holmes, S., Postlethwaite, D., & Carty, D. (2012). The role of integrated care pathways in improving the patient experience. Prof Nurse; 18(2): 77-79.
[9]	Campbell, M, A. (2006). Development of clinical pathway for near term and premature infants in level 2 nursery Adv neonatal care. 6(3): 150-164.
[10]	Barros, S.R.A.F., Pereira, S.S.L & Almeida, N.A. (2017). A formacao de academicos de enfermagem quanto a percepcao .Rev Dor 2011: 12(2): 131-7.
[11]	Zanatta, D.A., Rossini, M & Junior, A.T. (2017). Pyelonephritis in pregnancy: clinical and laboratorial aspects and perinatal results. Rev Bras Ginecol Obestet 2017, 39: 653-658.
[12]	Clooney, A., Ronayne, K., Glennon, M., Brennan, N., Hickey, C., Magee, S., Cooley, M & Eogan, R.J. (2019). Impact of introduction of clinical pathway for the management of pyelonephritis on obstetric patients.
[13]	Kazemier, B. M., Schneeberger, C., De Miranda, E., Van Wassenaer, A., Bossuyt, P. M., Vogelvang, T. E., ... & Geerlings, S. E. (2012). Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC pregnancy and childbirth, 12(1), 1-5.
[14]	El-Razek A., Heba A., Aziza A., & Abear Y. (2012). Effect of Pyelonephritis during pregnancy on Mother's Quality of Life. 4th (ISNC) Faculty of Nursing Helwan Universityin Collaboration with Kennesaw University (KSU), USA.
[15]	Silveira, M.F., Barros, A.J.D., Santos, I.S., et al. (2016). Exam de urina no prenatal. 42(3): 389-95.
[16]	Radwan, R.A. (2013). Self care practices among women with common gynecological symptoms. Alexandria university: Egypt 26-29.
[17]	Michael, E. (2017). Urinary tract infection and its effect on outcome of pregnancy, Indian journal of obstetrics and gynecology research. 4(2): 108-111.
[18]	Colgan, R., Williams, M., & Johnson, J. R. (2013). Diagnosis and treatment of acute pyelonephritis in women. American family physician, 84(5), 519-526.
[19]	Jarvis, T.R., Chan, L., & Gottlieb, T. (2014). “Assessment and management of lower urinary tract infection in adults”. Australian Prescriber 37 (1): 7-9.